Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human SRSF1 Antikörper:
anti-Mouse (Murine) SRSF1 Antikörper:
anti-Rat (Rattus) SRSF1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal SRSF1 Primary Antibody für ICC, IF - ABIN4353084
Brown, Dobrikov, Gromeier et al.: Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated ... in Journal of virology 2014
Show all 2 Pubmed References
Cow (Bovine) Polyclonal SRSF1 Primary Antibody für IHC, WB - ABIN2779013
Velazquez-Dones, Hagopian, Ma, Zhong, Zhou, Ghosh, Fu, Adams: Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty. in The Journal of biological chemistry 2005
Show all 2 Pubmed References
DLP (zeige DMD Antikörper) and ASF1 are part of a predeposition complex, which is recruited by XNP (zeige ATRX Antikörper) and is necessary to prevent DNA exposure in the nucleus.
ASF1 cellular levels are tightly controlled by distinct pathways and provide a molecular mechanism for post-translational regulation of dASF1 and hASF1a (zeige ASF1A Antikörper) by TLK (zeige TLK2 Antikörper) kinases.
dASF1 has a direct role in modifying chromatin structure during DNA replication and this function of dASF1 is important for the processivity of the replication machinery.
Asf1 is directed via interactions with sequence-specific complexes to mediate silencing of specific target genes.
Histone chaperones ASF1 and NAP1 (zeige NAP1L1 Antikörper) differentially modulate removal of active histone marks by LID-RPD3 (zeige HDAC1 Antikörper) complexes during NOTCH (zeige NOTCH1 Antikörper) silencing.
Immune suppression of JC virus gene expression is mediated by SRSF1.
ASF/SF2 is identified as a splicing regulator (zeige PTBP2 Antikörper) of cyclin T1 (zeige CCNT1 Antikörper), which contributes to the control of the subsequent transcription events.
Findings suggest MALAT1 increases AKAP-9 (zeige AKAP9 Antikörper) expression by promoting SRPK1 (zeige SRPK1 Antikörper)-catalyzed SRSF1 phosphorylation in CRC (zeige CALR Antikörper) cells. These results reveal a novel molecular mechanism by which MALAT1 regulates AKAP-9 (zeige AKAP9 Antikörper) expression in CRC (zeige CALR Antikörper) cells.
high level of SF2, as a novel oncoprotein in RCC (zeige XRCC1 Antikörper), was significantly associated with poor survival in a large cohort of RCC (zeige XRCC1 Antikörper) specimens. Taken together, our study presents a road map for the prediction and validation of miR (zeige MLXIP Antikörper)-766-3p/SF2 axis and thus imparts a therapeutic way for further RCC (zeige XRCC1 Antikörper) progression.
The authors found that RNA recognition motif 1 (RRM1) in SRSF1 binds PP1 and represses its catalytic function through an allosteric mechanism.
We present a joint atomistic molecular dynamics (MD) and experimental study of two RRM-containing proteins bound with their single-stranded target RNAs, namely the Fox-1 (zeige A2BP1 Antikörper) and SRSF1 complexes.The simulations predict unanticipated specific participation of Arg142 at the protein-RNA interface of the SRFS1 complex, which is subsequently confirmed by NMR and ITC measurements
Using NMR spectroscopy with two separately expressed domains of SRSF1, we showed that several residues in the RNA-binding motif 2 interact with the N-terminal region of the RS domain (RS1 (zeige RS1 Antikörper)).
Especially, in SRSF1 morphants, bone cartilage formation was reduced in the brain and Nkx-2.5 (zeige NKX2-5 Antikörper) expression was dramatically reduced in the heart of SRSF1 morphants. In addition, a dramatic reduction in functional chordin (zeige CHRD Antikörper) RNA in SRSF1 morphants was observed suggesting that chordin (zeige CHRD Antikörper) is one of the targets of SRSF1. Thus, we concluded that SRSF1 is an essential factor for pattern formation including heart, cartilage and germ lay
results strongly support SRSF1 as a prognostic biomarker in SCLC and provide a rationale for personalized therapy in SCLC
NSrp70 (zeige NSRP1 Antikörper) acts as a new molecular counterpart for alternative splicing of target RNA, counteracting SRSF1 and SRSF2 (zeige SRSF2 Antikörper) splicing activity.
The expression levels of three splicing factors, ESRP1 (zeige ESRP1 Antikörper), PTB (zeige PTBP1 Antikörper) and SF2/ASF, are significantly altered during cardiac hypertrophy in mice.
RRP1B suppresses metastatic progression by altering the transcriptome through its interaction with splicing regulators such as SRSF1
Deletion of RRM1 (zeige RRM1 Antikörper) eliminated the splicing activity of SRSF1 and thus cellular transformation.
Specific effects on regulated splicing by SR proteins SRSF1 and SRSF2 (zeige SRSF2 Antikörper) depends on a complex set of relationships with multiple other SR proteins in mammalian genomes.
Treatment with IL-17 (zeige IL17A Antikörper) prolongs the half-life of chemokine (zeige CCL1 Antikörper) CXCL1 (zeige CXCL1 Antikörper) mRNA via the adaptor TRAF5 (zeige TRAF5 Antikörper) and the splicing-regulatory factor SF2 (ASF).
analysis of the miRNA-mediated interaction between leukemia/lymphoma-related factor (LRF (zeige ZBTB7A Antikörper)) and alternative splicing factor/splicing factor (zeige SLU7 Antikörper) 2 (ASF/SF2) affects cell senescence and apoptosis
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 (zeige SMN1 Antikörper) causes spinal muscular atrophy in the absence of SMN1 (zeige SMN1 Antikörper)
Both hnRNP A1 (zeige HNRNPA1 Antikörper) and alternative splicing factor/splicing factor (zeige SLU7 Antikörper) 2 contents rose in adenomas and during injury-induced hyperplasia compared to control lungs
These results highlight the requirement of Sfrs1-mediated alternative splicing for the survival of retinal neurons, with sensitivity defined by the window of time in which the neuron was generated.
This gene encodes a member of the arginine/serine-rich splicing factor protein family, and functions in both constitutive and alternative pre-mRNA splicing. The protein binds to pre-mRNA transcripts and components of the spliceosome, and can either activate or repress splicing depending on the location of the pre-mRNA binding site. The protein's ability to activate splicing is regulated by phosphorylation and interactions with other splicing factor associated proteins. Multiple transcript variants encoding different isoforms have been found for this gene. In addition, a pseudogene of this gene has been found on chromosome 13.
, anti- silencing function 1
, anti-silencing factor
, splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)
, SR splicing factor 1
, alternative-splicing factor 1
, pre-mRNA-splicing factor SF2, P33 subunit
, splicing factor 2
, splicing factor, arginine/serine-rich 1
, splicing factor arginine/serine-rich 1
, splicing factor, arginine/serine-rich 1B
, pre-mRNA-splicing factor SRp30a
, splicing factor, arginine/serine-rich 1 (ASF/SF2)
, serine/arginine-rich splicing factor 1B
, splicing factor, arginine/serine-rich 1b